Next Article in Journal
Nuclear Factor Erythroid 2-Related Factor 2 and SARS-CoV-2 Infection Risk in COVID-19-Vaccinated Hospital Nurses
Next Article in Special Issue
The Role of Anti-Interferon-α Autoantibodies in Severe COVID-19: Implications for Vaccination Prioritization
Previous Article in Journal
Antibody Responses Following Primary Immunization with the Recombinant Herpes Zoster Vaccine (Shingrix®) in VZV Seronegative Immunocompromised Adults
Previous Article in Special Issue
Long-Term Immuno-Response and Risk of Breakthrough Infection After SARS-CoV-2 Vaccination in Kidney Transplantation
 
 
Article

Article Versions Notes

Vaccines 2025, 13(7), 738; https://doi.org/10.3390/vaccines13070738
Action Date Notes Link
article xml file uploaded 9 July 2025 09:55 CEST Original file -
article xml uploaded. 9 July 2025 09:55 CEST Update https://www.mdpi.com/2076-393X/13/7/738/xml
article pdf uploaded. 9 July 2025 09:55 CEST Version of Record https://www.mdpi.com/2076-393X/13/7/738/pdf
article supplementary file uploaded. 9 July 2025 09:55 CEST - https://www.mdpi.com/2076-393X/13/7/738#supplementary
article html file updated 9 July 2025 09:58 CEST Original file https://www.mdpi.com/2076-393X/13/7/738/html
Back to TopTop